Human CLDN18-A1 Virus-Like Particles

Human CLDN18-A1 Virus-Like Particles (VLPs) represent a specialized tool in membrane protein research, designed to display the full-length human Claudin-18 isoform A1 in its native, multimeric state. Claudin-18 is a key component of tight junction strands, with the A1 isoform being specifically expressed in the pulmonary epithelium to regulate paracellular permeability. These VLPs are produced using advanced mammalian or insect expression systems that allow the protein to self-assemble into non-infectious, nanostructured particles that mimic the structure of a viral envelope. Unlike traditional detergent-solubilized proteins, VLPs preserve the complex four-transmembrane domain architecture and the critical extracellular loops of CLDN18.1 within a stable lipid environment. This structural integrity is essential for maintaining biologically relevant epitopes, effectively overcoming the common hurdles of protein instability and misfolding that typically occur during the extraction and purification of highly hydrophobic membrane proteins.

The applications of Human CLDN18-A1 VLPs are extensive within drug discovery and diagnostic development. They serve as optimal antigens for the generation of high-affinity antibodies, presenting the target within a lipid bilayer that mirrors the natural cell membrane environment. This format is particularly effective for screening monoclonal antibodies via ELISA, Surface Plasmon Resonance (SPR), or phage display libraries. Beyond antibody discovery, these particles are integrated into functional assays to investigate tight junction dynamics and membrane permeability. Scientists frequently use CLDN18-A1 VLPs as critical controls in comparative studies alongside the CLDN18.2 isoform to verify the specificity of oncology drugs, ensuring that therapeutic candidates do not inadvertently target healthy lung tissue. Their inherent stability and high immunogenicity also facilitate their use as reference standards for quantifying protein expression levels in various clinical and bioanalytical settings.